Major Trial: A Win-Win in Treating Good-risk DCISMajor Trial: A Win-Win in Treating Good-risk DCIS

At 7 years, the rate of recurrence in ductal carcinoma in situ (DCIS) is low with breast-conserving surgery alone. But the addition of radiotherapy makes the rate even better. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news